ABSTRACT
Introduction .............................................................................................................. 18 HER Tyrosine Kinase Inhibitors .............................................................................. 18
Small Molecules .................................................................................................. 18 Monoclonal Antibodies .......................................................................................22 Other EGFR Inhibitors ........................................................................................22
Predictors of Response .............................................................................................23 Clinical Development of Inhibitors of the HER Family ..........................................25
